ArticleScientific reports2025
Quality control of hospitals and its effect on hospitalized fatality rate of COVID-19.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Spatially varying coefficient generalized distributed lag models for binary response with MCEM estimation.BMC medical research methodology · 2026Article
- Enhancing the forecast accuracy of the daily number of patients arrivals in emergency department by hybrid ARIMAX-ANN algorithm.PloS one · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The reported fatality rate of COVID-19 was significantly differ between different countries, provinces in a country, and hospitals in a province. It is important to find and analysed the source of variation in fatality rates to control future epidemics of infection disease. This study propose an approach to investigates the hospital quality of care and its impact on the in-hospital fatality rates of COVID-19 among over 30 years old patients in Iran. The study included 78,217 COVID-19 hospitalized patients over 30 years old from 34 hospitals in Razavi Khorasan province between January 20, 2020, and June 20, 2021. Attribute control charts were employed to evaluate the quality of care in hospitals during four peaks of COVID-19. To account for the impact of hospital quality on in-hospital fatality rates by adjusting on patient characteristics, two predictive models; Poisson and Binomial regression were utilized. The adjusted odds ratio of COVID-19 fatality in no quality confirmed (NQC) hospitals to the quality confirmed (QC) hospitals is 3.48 C.I.95% (2.38, 5.10) at the first peak among patients without other risk factors. The significant negative interactions with QC and peaks indicates that the provision of quality care serves to mitigate the risk of fatality in NQC hospitals during these peaks. The significant negative interaction between diabetes and QC demonstrated that the relative risk in NQC hospitals for no diabetes patient is higher than diabetic patients. There is no significant interaction between age, SaO2, and ARDS with QC; it means that the odds of fatality in NQC hospitals is not depends to these factors. The use of attribute control charts facilitated timely identification of trends and outliers, enabling proactive interventions to enhance patient care. This research underscores the critical role of hospital quality in managing patient outcomes during the COVID-19 pandemic and emphasizes the necessity for continuous monitoring and quality improvement initiatives in healthcare settings. The findings advocate for collaborative efforts among healthcare providers to implement best practices, particularly during surges in cases, to optimize resource allocation and improve overall quality of care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.